MRC1 and neoplasm: Similar to BM, the overall proportions of MΦ did not change upon treatments (Fig. 7Bi–ii), but the proportion of host protumoral M2-like CD206+ MΦ decreased significantly in tumor tissues from double-treated mice (Fig. 7Biii).